Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Inguinal hernia repair is one of the most commonly performed surgical procedures worldwide. Despite being classified as a minor surgical intervention, moderate to severe postoperative pain is reported in approximately 60% of patients. In a subset of these patients, acute postoperative pain may persist and evolve into chronic post-surgical inguinal pain, significantly affecting quality of life.
In recent years, beyond the use of systemic intravenous analgesics, ultrasound-guided fascial plane blocks have been increasingly incorporated into multimodal analgesia protocols with the aim of reducing postoperative opioid consumption and improving pain control. However, the current literature does not provide definitive evidence regarding the superiority of one block technique over another in this surgical population.
The primary objective of the present study is to compare the analgesic efficacy of the Quadro-iliac Plane Block (QIPB) and the transversus abdominis plane block (TAPB) in patients undergoing inguinal hernia repair.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| TAPB | Active Comparator | After the patients were placed under observation, positioned in the supine position, and appropriate area sterilization was performed, TAPB was administered to the patients with 30 ml of 0.25% bupivacaine under ultrasound guidance. |
|
| QIPB | Active Comparator | After the patients were placed under observation, positioned in the lateral decubitus position, and appropriate area sterilization was performed, QIPB was administered to the patients with 30 ml of 0.25% bupivacaine under ultrasound guidance. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| TAPB | Procedure | Patients will undergo TAPB procedure using 30 ml of 0.25% bupivacaine under ultrasound guidance. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Pain Score | Pain will be assessed using a visual analog scale from 0 mm (no pain) to 100 mm (worst pain) at rest and when coughing. Pain assessment will be made at 0, 1, 6, 12, 18, and 24 hours after surgery. | Up to 24 hours |
| Measure | Description | Time Frame |
|---|---|---|
| Patient Satisfaction | Quality of recovery-15 (QoR-15) score was used as the satisfaction score. The patient-reported Turkish QoR-15 score includes 15 questions that evaluate the patient's postoperative recovery. The QoR-15 score is grouped under two groups, A and B. A high QoR-15 score, a score between 0 (poor) and 10 (excellent) for each item, and a total score of 150 indicate better quality of recovery. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Ibrahim Topcu, MD | Contact | +905437860316 | ibrahimtpc78@gmail.com | |
| Musa Zengin, Associate Professor | Contact | +905307716235 | musazengin@gmail.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Ankara Etlik City Hospital | Recruiting | Ankara | Yenimahalle\Ankara | 06170 | Turkey (Türkiye) |
Not provided
Not provided
Not provided
Not provided
Not provided
| QIPB | Procedure | Patients will undergo QIPB procedure using 30 ml of 0.25% bupivacaine under ultrasound guidance. |
|
| 24th hour |
| ID | Term |
|---|---|
| D000377 | Agnosia |
| D006552 | Hernia, Inguinal |
| ID | Term |
|---|---|
| D010468 | Perceptual Disorders |
| D019954 | Neurobehavioral Manifestations |
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D046449 | Hernia, Abdominal |
| D006547 | Hernia |
| D020763 | Pathological Conditions, Anatomical |
Not provided
Not provided
| ID | Term |
|---|---|
| C074442 | 1,3-bis(4-amidinophenoxy)-2-(4-amidinophenoxymethyl)ethylpropane |
Not provided
Not provided
Not provided